BlockBeats News, April 30th, according to official sources, the DePIN project Kairos has completed its seed round financing, led by Vertex Capital (UK), HKIFS (Hong Kong), and Oaktree Capital Management (US) jointly.
Kairos is focused on building a DePIN resource network for the AI Agent era, aiming to bridge the collaborative path between edge hardware and intelligent body computing. Its flagship product is the world's first mass-produced blood pressure monitoring smart ring, accompanied by a distributed health data computing ecosystem.
It is reported that Kairos has achieved the large-scale implementation of medical-grade sensor modules, and the core team has a background in chip design and manufacturing. The project's data encryption architecture complies with the HIPAA medical compliance standard, demonstrating strong hardware delivery capabilities and a foundation of data security. Additionally, Kairos holds multiple core technology patents, including dual-system monitoring of blood pressure/blood lipids (TW112130535, CN202310968656.1, US184494,804), multi-sign fusion algorithm (TW114102843, CN202510101010.2), world's smallest medical-grade sensor module (TW114200663, CN202520109894.1), early screening algorithm for Parkinson's disease (TW114101216, CN202510041020.1), and a passive CIS fluidic system derived from missile fuel monitoring technology.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。